Efficacy and safety of trichloroacetate chemocauterization for pyriform sinus fistula

Efficacy and safety of trichloroacetate chemocauterization for pyriform sinus fistula - Trichloroacetate chemocauterization for pyriform sinus fistula

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020351

Enrollment

Registered

2015-12-25

Start date

2013-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pyrifirm sinus fistula

Interventions

chemocauterization of internal opening of pyriform sinus fistula with 30% trichloroacetate is performed under general anesthesia

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who was suffered from neck abscess caused by pyriform sinus fistula

Exclusion criteria

Exclusion criteria: Patients with severe renal or liver dysfunction, with a risk for general anesthesia, or whom a doctor considered not eligible

Design outcomes

Primary

Measure	Time frame
duration of recurrence-free observation	—

Countries

Japan

Contacts

Public ContactShigeyuki Murono

Kanazawa University Otolaryngology-Head and Neck Surgery

murono@med.kanazawa-u.ac.jp076-265-2413

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026